Mutagenic properties of allylic and α,β-unsaturated compounds: Consideration of alkylating mechanisms

Ames B. N., 1975, Mutation Res., 31, 347, 10.1016/0165-1161(75)90046-1

Brehe J. E., 1976, Analyt. Biochem., 74, 189, 10.1016/0003-2697(76)90323-7

10.3109/03602537409030009

Connors T. A. Fundamentals of Biochemistry and Pharmacology. Pergamon Press, Oxford 1971; 461

Dewolfe R. H., 1956, Chem. Rev., 56, 753, 10.1021/cr50010a002

Eder E., 1980, Biochem. Pharmac., 29, 993, 10.1016/0006-2952(80)90161-6

Eder E., 1982, Chemico-Biological Interactions, 38, 303, 10.1016/0009-2797(82)90060-6

England B. D., 1951, Nature Lond., 168, 1002, 10.1038/1681002b0

Kave C. M, 1973, Biochem. J., 134, 1093, 10.1042/bj1341093

Long E. L., 1963, Archs Path., 75, 595

Lutz D., 1982, Mutation Res., 93, 305, 10.1016/0027-5107(82)90146-4

McCoy E. C., 1978, Mutation Res., 57, 11, 10.1016/0027-5107(78)90242-7

Meijer J., 1980, Chemico-Biological Interactions, 31, 247, 10.1016/0009-2797(80)90013-7

10.1021/jo01333a010

Neudecker T., 1980, Biochem. Pharmac., 29, 2611, 10.1016/0006-2952(80)90075-1

Patel J. M., 1980, Drug Metab. Disp., 8, 305

Preussmann R., 1969, Arzneimittel-Forsch., 19, 1059

Public Health Service, 1978, NCI-CG-TR-73

Rannug U., 1976, Chemico-Biological Interactions, 12, 251, 10.1016/0009-2797(76)90041-7

Rosen I. D., 1980, Mutation Res., 78, 113, 10.1016/0165-1218(80)90090-7

Serafini-Cessi H, 1972, Biochem. J., 128, 1103, 10.1042/bj1281103

Singer B, 1976, Nature Lond., 264, 333, 10.1038/264333a0

Streitwieser A, 1956, Chem. Rev., 56, 573, 10.1021/cr50010a001

Van Duuren B. L., 1979, J. natn. Cancer Inst., 48, 1433

Vernon C. A, 1954, J. chem. Soc., 280

Wislocki P. G., 1976, Cancer Res., 36, 1686